History - Timeline

1887 – The Norwich Pharmacal Company in Norwich, NY is established, a partnership between Reverend Lafayette Moore and drug store employee Oscar G. Bell.

1893 – Norwich introduces Unguentine to the medical profession as the first antiseptic surgical dressing.

1901 – Mixture Cholera Infantum appears for the first time in a company sales catalog. Its principal use is for infants with severe diarrhea.

1907 – Acetylsalicylic acid (aspirin) tablets are added to the company’s product line.

1919 – Mixture Cholera Infantum is renamed Pepto-Bismol, which is still on the market under that name today.

1920 – Norwich offers approximately 4,000 elixirs, tinctures, syrups, pills, tablets, extracts, suppositories, dressings and surgical instruments in its product line.

1939 – Norwich Pharmacal stock is listed on the New York Stock Exchange.

1943-45 – Norwich Pharmacal Company is awarded a total of five Army-Navy "E" awards, a recognition of their war effort during World War II.

1969 – The company merges with Morton International, Inc., forming a new corporation, Morton-Norwich Products, Inc.

1982 – The company, now called Norwich Eaton Pharmaceuticals, becomes a wholly owned subsidiary of the Procter & Gamble Company.

1994-96 - Norwich constructs Intermediate Potency solid dose form facility, from which the osteoporosis drug Actonel is launched.

2001 – The Norwich, NY plant is purchased from Procter and Gamble Pharmaceuticals and transitions into its current role as an outsourcing provider to the pharmaceutical industry.  A long term contract is signed with P&G, is later extended, and remains in force today. 

Today - Norwich is on track to achieve its goal of growing the business, providing excellent customer service, and building on its record of regulatory mastery.